Immunogene therapy with fusogenic nanoparticles modulates macrophage response to Staphylococcus aureus

Abstract

In the context of increasing bacterial antibiotic-resistance, gene therapy that targets the immune system to clear infection is a major goal. Here the authors show a silicon based nanosystem that modulates the macrophage response in an in vivo model of Staphylococcal pneumonia.